Events

IRIDS Virtual Science Talks

Welcome to the IRIDS Virtual Science Talks
The spirit of IRIDS
 

IRIDS (International Roche Infectious Diseases Symposium) comprises a series of scientific and educational events taking place since 2009, addressing some of the most significant, up-to-date topics in the field of infectious disease (ID) management and diagnosis. IRIDS is the perfect forum for laboratory experts and clinical specialists from around the world, to exchange insights and expertise in the infectious diseases field.  

 

The IRIDS Virtual Science Talks
 

In 2022, and across 2023, several webinars will take place to engage, inform, and inspire healthcare professionals all over the world. Scientists and industry leaders will share their thoughts and experiences within the field of infectious diseases, on a platform built to facilitate and enhance conversations and sometimes also debates.

 

Three reasons to attend
 

Stay up to date on the global trends and most significant development on infectious diseases.

Discover more about trends and current innovations around SARS-CoV-2, viral hepatitis, sexual transmitted diseases, and congenital infection, just to mention a few.

Connect with lab experts, clinicians, industry leaders from other countries.

Attendance to the IRIDS Virtual is free of charge. No CME points will be provided, but it will be possible to get a Certificate of Attendance.

 

Register now for the upcoming IRIDS Virtual Science Talk

'Highly dangerous, highly unknown. Sharing knowledge on CMV prevention, and diagnosis' planned for April 13th, 2023 from 13:00 to 14:00 CET (date might still be subject to change. Speaker's name to be announced by January 2023)

Form Successfully Submitted!
Thank you for your submission!
text

References:

  1. Fowler, K., et al. A systematic literature review of the global seroprevalence of cytomegalovirus: possible implications for treatment, screening, and vaccine development. BMC Public Health 2022;22, 1659.
  2. Cannon MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol. 2009;46(Suppl 4):S6–10. pmid:19800841.
  3. United Nations. World Population Prospects 2022. [Internet; cited 2022 Nov 29]. Available from: https://population.un.org/wpp/Download/Standard/MostUsed/
  4. Perillaud-Dubois C, et al. Current practices of management of maternal and congenital Cytomegalovirus infection during pregnancy after a maternal primary infection occurring in first trimester of pregnancy: Systematic review. PLoS ONE 2022;16(12): e0261011.
  5. CDC. Congenital CMV Infection. [Internet; cited 2022 Nov 29]. Available from: https://www.cdc.gov/cmv/clinical/congenital-cmv.html#print
  6. Cannon M.J., Davis K.F. Washing our hands of the congenital cytomegalovirus epidemics. BMC Public Health. 2005;5:70.
  7. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19-11 March 2020. [Internet; 2020 March; cited 2022 October 13]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
  8. United Nations News. The end of the COVID-19 pandemic is in sight: WHO.  [Internet; 2022 September; cited 2022 October 13]. Available from: https://news.un.org/en/story/2022/09/1126621.